CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
53.39
+2.95 (5.85%)
At close: Oct 9, 2026, 4:00 PM EDT
53.69
+0.30 (0.56%)
After-hours: Oct 9, 2026, 7:57 PM EDT
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $5.16 billion as of October 9, 2026. It is the 3,557th most valuable company in the world and the 1,136th biggest in the United States. Its market cap has decreased by 26.07% in one year.
Market Cap
5.16B
Enterprise Value
3.58B
1-Year Change
-26.07%
Global Rank
Country Rank
#1,136 United States
Category
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $5.16B, an increase of 821.70%. That is a compound annual growth rate of 24.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 5.16B | 3.30% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CG Oncology | 5.71B |
| Mirum Pharmaceuticals | 5.68B |
| Veradermics | 5.63B |
| Erasca | 5.55B |
| Oruka Therapeutics | 5.38B |
| Cogent Biosciences | 5.35B |
| PTC Therapeutics | 5.30B |
| Scholar Rock Holding | 5.15B |